Yong-Su Zhen Selected Research

methoxypolyethyleneglycol- poly(lactic- co- glycolic acid)

1/2017

Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yong-Su Zhen Research Topics

Disease

61	Neoplasms (Cancer) 04/2024 - 02/2003
14	Carcinoma (Carcinomatosis) 11/2018 - 07/2004
12	Hepatocellular Carcinoma (Hepatoma) 01/2014 - 07/2004
11	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 06/2007
7	Neoplasm Metastasis (Metastasis) 11/2018 - 12/2003
5	Breast Neoplasms (Breast Cancer) 04/2024 - 11/2008
4	Lung Neoplasms (Lung Cancer) 04/2024 - 12/2003
4	Glioma (Gliomas) 08/2014 - 07/2009
3	Fibrosarcoma 11/2018 - 01/2011
3	Multiple Myeloma 07/2013 - 07/2009
2	Esophageal Squamous Cell Carcinoma 01/2019 - 01/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017 - 04/2017
2	Esophageal Neoplasms (Esophageal Cancer) 06/2017 - 01/2014
2	Colonic Neoplasms (Colon Cancer) 11/2016 - 06/2010
2	Colorectal Neoplasms (Colorectal Cancer) 07/2014 - 08/2005
2	Ovarian Neoplasms (Ovarian Cancer) 01/2014 - 01/2009
1	Triple Negative Breast Neoplasms 12/2021
1	Experimental Melanoma 01/2021
1	Inflammation (Inflammations) 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2004
27	C 1027IBA 01/2018 - 06/2005
11	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 06/2005
9	ErbB Receptors (EGF Receptor)IBA 12/2021 - 01/2009
6	Therapeutic UsesIBA 01/2020 - 07/2005
5	Immunoconjugates (Immunoconjugate)IBA 04/2024 - 01/2019
5	Gemcitabine FDA Link 01/2022 - 05/2008
4	AntigensIBA 04/2024 - 10/2012
4	Matrix Metalloproteinases (MMPs)IBA 11/2018 - 12/2003
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013 - 07/2005
4	Collagenases (Collagenase)FDA Link 06/2006 - 12/2003
3	Peptides (Polypeptides)IBA 01/2022 - 03/2013
3	DefensinsIBA 01/2022 - 09/2016
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 02/2011
3	ApoproteinsIBA 01/2018 - 05/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2014 - 06/2006
3	Fluorouracil (Carac)FDA LinkGeneric 01/2013 - 07/2004
3	rhein lysinateIBA 01/2009 - 11/2008
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2005 - 07/2004
2	Surface Antigens (Surface Antigen)IBA 04/2024 - 12/2023
2	EpitopesIBA 12/2023 - 01/2017
2	Dihydrotachysterol (AT 10)IBA 11/2023 - 07/2004
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2023 - 06/2007
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2022 - 12/2006
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021 - 01/2009
2	Human Serum Albumin FDA LinkGeneric 09/2021 - 01/2018
2	Drug CombinationsIBA 01/2020 - 01/2014
2	ubenimexIBA 01/2020 - 12/2012
2	AlbuminsIBA 01/2018 - 09/2012
2	Temozolomide (Temodar)FDA LinkGeneric 08/2014 - 04/2014
2	GelatinasesIBA 04/2013 - 10/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2013 - 12/2006
2	Vincristine (Oncovin)FDA LinkGeneric 01/2013 - 12/2004
2	Fluorescein-5-isothiocyanate (FITC)IBA 10/2012 - 04/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2009 - 01/2009
2	rheinIBA 01/2009 - 01/2009
2	NF-kappa B (NF-kB)IBA 05/2008 - 06/2007
2	UridineIBA 10/2005 - 07/2004
2	Monoclonal AntibodiesIBA 08/2005 - 12/2003
1	sacituzumab govitecanIBA 04/2024
1	Recombinant Fusion ProteinsIBA 01/2023
1	formaldehyde-serum albuminIBA 04/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2022
1	salinomycinIBA 01/2022
1	Epithelial Cell Adhesion MoleculeIBA 12/2021
1	ProdrugsIBA 09/2021
1	Nucleic AcidsIBA 01/2021
1	bleomycetinIBA 01/2021
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2020
1	Capecitabine (Xeloda)FDA Link 01/2020
1	IonophoresIBA 01/2019
1	Gramicidin (Gramicidin A)FDA LinkGeneric 01/2019
1	Sincalide FDA Link 01/2019
1	Recombinant ProteinsIBA 11/2018
1	Amino Acids FDA Link 01/2018
1	Insulin (Novolin)FDA Link 06/2017
1	Epidermal Growth Factor (EGF)IBA 06/2017
1	LigandsIBA 06/2017
1	Insulin-Like PeptidesIBA 04/2017
1	Neutral RedIBA 02/2017
1	Amiloride (Midamor)FDA LinkGeneric 02/2017
1	ethylisopropylamiloride (EIPA)IBA 02/2017
1	Histone Deacetylase InhibitorsIBA 02/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Sp1 Transcription FactorIBA 01/2017
1	mithramycin AIBA 01/2017
1	methoxypolyethyleneglycol- poly(lactic- co- glycolic acid)IBA 01/2017
1	Plicamycin FDA Link 01/2017
1	GalactosidasesIBA 11/2016
1	IMB5046IBA 11/2016
1	desferrioxamine-human serum albumin conjugateIBA 09/2016
1	TuftsinIBA 12/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014
1	geldanamycinIBA 01/2014

Therapy/Procedure

26	Therapeutics 04/2024 - 07/2004
6	Drug Therapy (Chemotherapy) 01/2020 - 12/2004
3	Intravenous Injections 03/2012 - 06/2005
1	Immunomodulation 09/2021
1	Injections 01/2019
1	Immunotherapy 01/2017